The challenge

Epilepsy is a common condition in which the patient experiences unpredictable seizures. It is estimated that there are 600,000 people with epilepsy living in the UK alone.

A seizure is always unpleasant and inconvenient but can be catastrophic resulting in serious injury and even death.

Over 30 percent of people with epilepsy struggle to get their seizures under control: their quality of life is among the lowest when compared with other health conditions. A real challenge for management is the unreliability of seizure diaries, which currently serve as a key tool in guiding treatment. Current EEG tools are time limited and do not show real-life events.

Furthermore, unrecognised seizures often stand in the way of accurate self-reporting and can conceal the true effect of medication.

The solution

Ultra long-term, objective seizure tracking represents a new way forward for epilepsy care and complements the tools currently available.

The 24/7 EEG™ SubQ solution allows for continuous EEG monitoring day and night for up to 15 months. This allows the patient to live their regular life and get on with day to day activities without feeling constrained, away from the hospital setting.

The subcutaneous implant and external recorder, combined with a complete data infrastructure and analytics software, provide automated seizure detection which allows the treating clinician to manage their patient remotely.

The 24/7 EEG™ SubQ solution reliably monitors the effect of treatment by tracking the number of electrographic seizures. Changes can be observed over months, allowing the seizure burden to be followed when titrating medication over longer periods of time.

If I was somebody with epilepsy, at the beginning of my epilepsy journey, I would have that thing put in to help when changing medication, discontinue medication, getting through rough times – having the thing in makes a whole lot of sense to me.

Dr Jacqueline A. French, Professor, Department of Neurology at NYU Grossman School of Medicine and Chief Medical and Innovation Officer for the Epilepsy Foundation

The impact

  • Manage patients remotely
  • Data on demand
  • Detect treatment effect with objective seizure counting
  • Identify seizure cycles
  • Empower patients